{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:53:12Z","timestamp":1790009592498,"version":"4.0.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020956","name":"Merck Healthcare KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.rbmo.2023.103725","type":"journal-article","created":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T01:17:41Z","timestamp":1699751861000},"page":"103725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35\u201340 years"],"prefix":"10.1016","volume":"48","author":[{"given":"Alexandra P","family":"Bielfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Enrique","family":"Schwarze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Verpillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Lispi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Chuderland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"D'Hooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Steffan","family":"Krussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2023.103725_bib0001","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1477-7827-7-101","article-title":"Biological versus chronological ovarian age: Implications for assisted reproductive technology","volume":"7","author":"Alviggi","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.rbmo.2023.103725_bib0002","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/humrep\/del284","article-title":"Clinical outcome following stimulation with highly purified hmg or recombinant fsh in patients undergoing ivf: A randomized assessor-blind controlled trial","volume":"21","author":"Andersen","year":"2006","journal-title":"Human reproduction (Oxford, England)"},{"key":"10.1016\/j.rbmo.2023.103725_bib0003","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/humrep\/del075","article-title":"Assisted reproductive technology in europe, 2002. Results generated from european registers by eshre","volume":"21","author":"Andersen","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2023.103725_bib0004","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1477-7827-12-128","article-title":"Human steroidogenesis: Implications for controlled ovarian stimulation with exogenous gonadotropins","volume":"12","author":"Andersen","year":"2014","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.1016\/j.rbmo.2023.103725_bib0005","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/molehr\/4.7.631","article-title":"Glycoform composition of serum gonadotrophins through the normal menstrual cycle and in the post-menopausal state","volume":"4","author":"Anobile","year":"1998","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.rbmo.2023.103725_bib0006","doi-asserted-by":"crossref","first-page":"S493","DOI":"10.1016\/j.fertnstert.2013.07.349","article-title":"A life birth predictive model after in vitro fertilization (ivf) may have a fair discrimination: Results of a multicenter external validation based on 15039 ivf cycles","volume":"100","author":"Arvis","year":"2013","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2023.103725_bib0007","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.rbmo.2020.08.035","article-title":"Effect of recombinant lh supplementation on cumulative live birth rate compared with fsh alone in poor ovarian responders: A large, real-world study","volume":"42","author":"Arvis","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2023.103725_bib0008","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.rbmo.2012.02.009","article-title":"Array cgh analysis shows that aneuploidy is not related to the number of embryos generated","volume":"24","author":"Ata","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2023.103725_bib0009","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41118-020-00108-0","article-title":"European countries with delayed childbearing are not those with lower fertility","volume":"77","author":"Beaujouan","year":"2021","journal-title":"Genus"},{"key":"10.1016\/j.rbmo.2023.103725_bib0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.rbmo.2015.06.002","article-title":"Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation","volume":"31","author":"Behre","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2023.103725_bib0011","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple hypothesis testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"10.1016\/j.rbmo.2023.103725_bib0012","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s12325-018-0805-y","article-title":"Interpretation and impact of real-world clinical data for the practicing clinician","volume":"35","author":"Blonde","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.rbmo.2023.103725_bib0013","first-page":"217","article-title":"D.I.R-annual 2017","volume":"15","author":"Blumenauer","year":"2018","journal-title":"J. Reproduktionsmedizin und Endokrinologie"},{"key":"10.1016\/j.rbmo.2023.103725_bib0014","first-page":"272","article-title":"D.I.R-annual 2018","volume":"16","author":"Blumenauer","year":"2019","journal-title":"Journal fur Reproduktionsmedizin und Endokrinologie"},{"key":"10.1016\/j.rbmo.2023.103725_bib0015","first-page":"196","article-title":"D.I.R-annual 2019","volume":"17","author":"Blumenauer","year":"2020","journal-title":"Journal fur Reproduktionsmedizin und Endokrinologie"},{"key":"10.1016\/j.rbmo.2023.103725_bib0016","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/humrep\/deab065","article-title":"Reduced fsh and lh action: Implications for medically assisted reproduction","volume":"36","author":"Bosch","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2023.103725_bib0017","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.fertnstert.2010.10.021","article-title":"Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: An age-adjusted analysis","volume":"95","author":"Bosch","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2023.103725_bib0018","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fendo.2018.00216","article-title":"In vivo and in vitro impact of carbohydrate variation on human follicle-stimulating hormone function","volume":"9","author":"Bousfield","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rbmo.2023.103725_bib0019","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/er.2009-0006","article-title":"Ovarian aging: Mechanisms and clinical consequences","volume":"30","author":"Broekmans","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.rbmo.2023.103725_bib0020","first-page":"29","article-title":"The german ivf-registry - d\u00b7i\u00b7r","volume":"10","author":"B\u00fchler","year":"2013","journal-title":"Journal fur Reproduktionsmedizin und Endokrinologie"},{"key":"10.1016\/j.rbmo.2023.103725_bib0021","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12958-021-00768-3","article-title":"Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hfsh-alfa) versus highly purified urinary human menopausal gonadotropin (hmg hp) in assisted reproductive technology (art) treatments: A non-interventional study in germany","volume":"19","author":"B\u00fchler","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.rbmo.2023.103725_bib0022","first-page":"996","volume":"35","author":"Carone","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.rbmo.2023.103725_bib0023","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10815-022-02456-6","article-title":"Regulation of antral follicular growth by an interplay between gonadotropins and their receptors","volume":"39","author":"Casarini","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.rbmo.2023.103725_bib0024","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mce.2015.12.008","article-title":"Follicle-stimulating hormone potentiates the steroidogenic activity of chorionic gonadotropin and the anti-apoptotic activity of luteinizing hormone in human granulosa-lutein cells in vitro","volume":"422","author":"Casarini","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.rbmo.2023.103725_bib0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1210\/er.2018-00065","article-title":"Two hormones for one receptor: Evolution, biochemistry, actions, and pathophysiology of lh and hcg","volume":"39","author":"Casarini","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.rbmo.2023.103725_bib0026","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.fertnstert.2009.11.018","article-title":"Measuring outcomes in fertility trials: Can we rely on clinical pregnancy rates?","volume":"94","author":"Clarke","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2023.103725_bib0027","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12958-019-0460-4","article-title":"The role of recombinant lh in women with hypo-response to controlled ovarian stimulation: A systematic review and meta-analysis","volume":"17","author":"Conforti","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.rbmo.2023.103725_bib0028","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12958-021-00759-4","article-title":"Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: A systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Conforti","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.rbmo.2023.103725_bib0029","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: Changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rbmo.2023.103725_bib0030","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/humrep\/dey242","article-title":"Art in europe, 2014: Results generated from european registries by eshre: The european ivf-monitoring consortium (eim) for the european society of human reproduction and embryology (eshre)","volume":"33","author":"De Geyter","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2023.103725_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.907249","article-title":"Luteinizing hormone supplementation in women with hypogonadotropic hypogonadism seeking fertility care: Insights from a narrative review","volume":"13","author":"Di Segni","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rbmo.2023.103725_bib0032","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3389\/fendo.2019.00814","article-title":"The poseidon criteria and its measure of success through the eyes of clinicians and embryologists","volume":"10","author":"Esteves","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rbmo.2023.103725_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.587051","article-title":"Improving reporting of clinical studies using the poseidon criteria: Posort guidelines","volume":"12","author":"Esteves","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rbmo.2023.103725_bib0034","unstructured":"Eurostat, 2022. Older mothers - european commission."},{"key":"10.1016\/j.rbmo.2023.103725_bib0035","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10815-023-02757-4","article-title":"The hera (hyper-response risk assessment) delphi consensus definition of hyper-responders for in-vitro fertilization","volume":"40","author":"Feferkorn","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.rbmo.2023.103725_bib0036","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.fertnstert.2004.06.041","article-title":"Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques","volume":"82","author":"Ferraretti","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2023.103725_bib0037","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"Eshre consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: The bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2023.103725_bib0038","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/birt.12089","article-title":"Characteristics of primiparous women of advanced age and their partners: A homogenous or heterogenous group?","volume":"41","author":"Guedes","year":"2014","journal-title":"Birth"},{"key":"10.1016\/j.rbmo.2023.103725_bib0039","unstructured":"Hayes, F., Dwyer, A., Pitteloud, N., 2000. Hypogonadotropic hypogonadism (hh) and gonadotropin therapy. In: Feingold, K.R., et al. (Eds.) Endotext. South Dartmouth (MA)."},{"key":"10.1016\/j.rbmo.2023.103725_bib0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.rbmo.2016.11.010","article-title":"Model' versus 'everyday' patients: Can randomized controlled trial data really be applied to the clinic?","volume":"34","author":"Hershkop","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2023.103725_bib0041","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1472-6483(10)61643-4","article-title":"Effects of recombinant lh supplementation in women undergoing assisted reproduction with gnrh agonist down-regulation and stimulation with recombinant fsh: An opening study","volume":"8","author":"Humaidan","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2023.103725_bib0042","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dex208","article-title":"Efficacy and safety of follitropin alfa\/lutropin alfa in art: A randomized controlled trial in poor ovarian responders","volume":"32","author":"Humaidan","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2023.103725_bib0043","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-2004-831896","article-title":"Inhibins, activins, and follistatin in the aging female and male","volume":"22","author":"Hurwitz","year":"2004","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.rbmo.2023.103725_bib0044","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1055\/s-0042-108576","article-title":"The german ivf register as an instrument to document assisted reproductive technologies","volume":"76","author":"Kadi","year":"2016","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.rbmo.2023.103725_bib0045","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.3346\/jkms.2018.33.e213","article-title":"Real-world evidence versus randomized controlled trial: Clinical research based on electronic medical records","volume":"33","author":"Kim","year":"2018","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.rbmo.2023.103725_bib0046","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/humrep\/den061","article-title":"Change, change, change: Hormonal actions depend on changes in blood levels","volume":"23","author":"Kol","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2023.103725_bib0047","author":"Koloda","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.rbmo.2023.103725_bib0048","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in ivf using ovarian reserve markers: From theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.rbmo.2023.103725_bib0049","first-page":"25","article-title":"Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea","volume":"83","author":"Laughlin","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rbmo.2023.103725_bib0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.rbmo.2018.03.013","article-title":"Predicting live birth for poor ovarian responders: The prosper concept","volume":"37","author":"Lehert","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2023.103725_bib0051","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7827-12-17","article-title":"Recombinant human follicle-stimulating hormone (r-hfsh) plus recombinant luteinizing hormone versus r-hfsh alone for ovarian stimulation during assisted reproductive technology: Systematic review and meta-analysis","volume":"12","author":"Lehert","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.rbmo.2023.103725_bib0052","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/humrep\/dey263","article-title":"Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: An external validation study","volume":"33","author":"Leijdekkers","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2023.103725_bib0053","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fendo.2019.00282","article-title":"An observational retrospective cohort trial on 4,828 ivf cycles evaluating different low prognosis patients following the poseidon criteria","volume":"10","author":"Levi-Setti","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rbmo.2023.103725_bib0054","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1472-6483(10)61610-0","article-title":"Use of recombinant lh in a group of unselected ivf patients","volume":"5","author":"Lisi","year":"2002","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2023.103725_bib0055","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.fertnstert.2014.05.020","article-title":"A prediction model for live birth and multiple births within the first three cycles of assisted reproductive technology","volume":"102","author":"Luke","year":"2014","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2023.103725_bib0056","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0378-5122(84)90015-X","article-title":"Decrease in luteinizing hormone biological activity\/immunoreactivity ratio in elderly men","volume":"5","author":"Marrama","year":"1984","journal-title":"Maturitas"},{"key":"10.1016\/j.rbmo.2023.103725_bib0057","first-page":"1","article-title":"Births: Final data for 2009","volume":"60","author":"Martin","year":"2011","journal-title":"National Vital Statistics Reports"},{"key":"10.1016\/j.rbmo.2023.103725_bib0058","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/humrep\/dev336","article-title":"Cumulative live birth rates after one or more complete cycles of ivf: A population-based study of linked cycle data from 178,898 women","volume":"31","author":"Mclernon","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2023.103725_bib0059","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.fertnstert.2021.09.015","article-title":"Predicting personalized cumulative live birth following in vitro fertilization","volume":"117","author":"Mclernon","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2023.103725_bib0060","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1210\/en.2007-0046","article-title":"Rising follicle-stimulating hormone levels with age accelerate female reproductive failure","volume":"148","author":"Mctavish","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2023.103725_bib0061","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/clinchem\/41.8.1139","article-title":"Immunometric assays of luteinizing hormone (lh): Differences in recognition of plasma lh by anti-intact and beta-subunit-specific antibodies in various physiological and pathophysiological situations","volume":"41","author":"Mitchell","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.rbmo.2023.103725_bib0062","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.fertnstert.2018.04.037","article-title":"Personalized ovarian stimulation for assisted reproductive technology: Study design considerations to move from hype to added value for patients","volume":"109","author":"Mol","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2023.103725_bib0063","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/eb-2017-102701","article-title":"The limitations of using randomised controlled trials as a basis for developing treatment guidelines","volume":"21","author":"Mulder","year":"2018","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.rbmo.2023.103725_bib0064","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0015-0282(16)58203-X","article-title":"Evidence for diminished midcycle ovarian androgen production in older reproductive aged women","volume":"65","author":"Mushayandebvu","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2023.103725_bib0065","series-title":"Vital statistics of the united states, 1980","year":"1984"},{"key":"10.1016\/j.rbmo.2023.103725_bib0066","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/09513590903215516","article-title":"Lh supplementation in down-regulated women undergoing assisted reproduction with baseline low serum lh levels","volume":"26","author":"Pezzuto","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.rbmo.2023.103725_bib0067","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/humrep\/dev149","article-title":"Sub-optimal responders following controlled ovarian stimulation: An overlooked group?","volume":"30","author":"Polyzos","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2023.103725_bib0068","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: From a poor ovarian response to a low prognosis concept","volume":"105","author":"Poseidon","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2023.103725_bib0069","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/humrep\/dez258","article-title":"A systematic review of the quality of clinical prediction models in in vitro fertilisation","volume":"35","author":"Ratna","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2023.103725_bib0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12958-015-0080-6","article-title":"Controlled ovarian stimulation with recombinant-fsh plus recombinant-lh vs. Human menopausal gonadotropin based on the number of retrieved oocytes: Results from a routine clinical practice in a real-life population","volume":"13","author":"Revelli","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.rbmo.2023.103725_bib0071","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.fertnstert.2006.06.059","article-title":"Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures","volume":"87","author":"Ruvolo","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2023.103725_bib0072","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence - what is it and what can it tell us?","volume":"375","author":"Sherman","year":"2016","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.rbmo.2023.103725_bib0073","series-title":"Lh increases the response to fsh in granulosa-lutein cells from sub\/poor-responder patients in vitro","author":"Sperduti","year":"2022"},{"key":"10.1016\/j.rbmo.2023.103725_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2016.02.028","article-title":"Impact of female age and nulligravidity on fecundity in an older reproductive age cohort","volume":"105","author":"Steiner","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2023.103725_bib0075","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/humrep\/deaa138","article-title":"Time as an outcome measure in fertility-related clinical studies: Long-awaited","volume":"35","author":"Sunkara","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2023.103725_bib0076","doi-asserted-by":"crossref","first-page":"305","DOI":"10.11622\/smedj.2014081","article-title":"Female ageing and reproductive outcome in assisted reproduction cycles","volume":"55","author":"Tan","year":"2014","journal-title":"Singapore Med J"},{"key":"10.1016\/j.rbmo.2023.103725_bib0077","first-page":"1507","article-title":"Recombinant human luteinizing hormone (lh) to support recombinant human follicle-stimulating hormone (fsh)-induced follicular development in lh- and fsh-deficient anovulatory women: A dose-finding study. The european recombinant human lh study group","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rbmo.2023.103725_bib0078","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/humrep\/16.4.599","article-title":"Is there any physiological role for gonadotrophin oligosaccharide heterogeneity in humans?: I. Gondatrophins are synthesized and released in multiple molecular forms. A matter of fact","volume":"16","author":"Ulloa-Aguirre","year":"2001","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2023.103725_bib0079","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1530\/eje.0.1340357","article-title":"Gonadotropins and gonadotropin receptors during the perimenopause","volume":"134","author":"Vihko","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.rbmo.2023.103725_bib0080","unstructured":"Who, 2021. Who laboratory manual for the examination and processing of human semen."},{"key":"10.1016\/j.rbmo.2023.103725_bib0081","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1210\/jc.2007-1342","article-title":"Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men","volume":"92","author":"Wide","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rbmo.2023.103725_bib0082","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/humrep\/deac030","article-title":"Are we leaving money on the table in infertility rcts? Trialists should statistically adjust for prespecified, prognostic covariates to increase power","volume":"37","author":"Wilkinson","year":"2022","journal-title":"Human reproduction (Oxford, England)"},{"key":"10.1016\/j.rbmo.2023.103725_bib0083","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The international glossary on infertility and fertility care, 2017","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2023.103725_bib0084","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12958-022-01014-0","volume":"20","author":"Zhang","year":"2022","journal-title":"Reprod Biol Endocrinol"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648323008246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648323008246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:08:48Z","timestamp":1758989328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648323008246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1472648323008246"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2023.103725","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35\u201340 years","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2023.103725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103725"}}